U.S. Court Expedites Appeal to Re-Launch Generic Opioid Addiction Drug U.S. Court Expedites Appeal to Re-Launch Generic Opioid Addiction Drug

August 9, 2018

Indivior said on Monday a U.S. Court expedited a generic rival’s appeal against a preliminary injunction that blocked the sale of a copycat version of the British drugmaker’s blockbuster opioid addiction treatment, Suboxone Film (buprenorphine and naloxone).Reuters Health Information (Source: Medscape Medical News Headlines)

Read the full article →

U.S. Court Expedites Appeal to Re-Launch Generic Opioid Addiction Drug U.S. Court Expedites Appeal to Re-Launch Generic Opioid Addiction Drug

August 9, 2018

Indivior said on Monday a U.S. Court expedited a generic rival’s appeal against a preliminary injunction that blocked the sale of a copycat version of the British drugmaker’s blockbuster opioid addiction treatment, Suboxone Film (buprenorphine and naloxone).Reuters Health Information (Source: Medscape Medical News Headlines)

Read the full article →

U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

August 9, 2018

The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

August 9, 2018

The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

When an Iowa Family Doctor Takes On the Opioid Epidemic

July 20, 2018

Few primary care doctors are willing to do what Nicole Gastala has: endure the challenges of prescribing buprenorphine, a medication for opioid addiction. (Source: NYT Health)

Read the full article →

The Satisfaction of Suboxone Treatment

July 20, 2018

(MedPage Today) — It’s become the most comprehensive, integrated thing that I do (Source: MedPage Today Psychiatry) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

After Opioid Overdose, Only 30% Get Medicine to Treat Addiction After Opioid Overdose, Only 30% Get Medicine to Treat Addiction

June 21, 2018

Patients revived from an opioid overdose who get methadone or Suboxone treatment for addiction afterward are much more likely to be alive a year later, says a study published in the Annals of Internal Medicine.Kaiser Health News (Source: Medscape Medical News Headlines) MedWorm Message: Have you tried our new medical search engine? More powerful than […]

Read the full article →

Dr Reddy's gets temporary restraining order on sale of generic Suboxone film in US

June 18, 2018

Dr Reddy’s said in a BSE filing that the company remains confident in its legal positions on this patent. (Source: The Economic Times Healthcare and Biotech News)

Read the full article →

FDA approves first generic Suboxone

June 18, 2018

Mylan and Dr. Reddy’s Laboratories have both received FDA approval to make the first generic versions of a Suboxone under-the-tongue film for the treatment of opioid addiction. (Source: PharmaManufacturing.com) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

FDA approves first generic sublingual film to treat opioid addiction

June 16, 2018

The FDA this week approved the first generic version of Indivior‘s (LON:INDV) billion-dollar opioid addiction treatment, Suboxone. The generic buprenorphine and naloxone sublingual film, sold by Dr. Reddy’s Laboratories (NYSE:RDY) and Mylan (NSDQ:MYL), is designed to suppress withdrawal symptoms that crop in people addicted to opioids, as well as block the neurochemical effects of opioids. Get the […]

Read the full article →